| 2005 |
BRF-1 contains two activation domains (N-terminal and C-terminal) that recruit mRNA decay enzymes involved in deadenylation, decapping, and both 3'-to-5' and 5'-to-3' exonucleolytic decay; the N-terminal activation domain functions as a binding platform for mRNA decay enzymes, linking ARE-containing mRNAs to the decay machinery. |
Co-immunoprecipitation, tethering assays with heterologous RNA-binding protein fusions, dominant-negative overexpression, in vivo mRNA decay assays |
Genes & development |
High |
15687258
|
| 2007 |
TTP and BRF-1 deliver ARE-mRNAs to processing bodies (PBs) to promote translational silencing; TTP/BRF-1 can nucleate PB formation on untranslated mRNAs, and this occurs downstream of polysome release via their N- and C-terminal domains. |
siRNA depletion, dominant-negative mutants, tethering assays, fluorescence microscopy, cycloheximide polysome trapping |
Genes & development |
High |
17369404
|
| 2002 |
BRF1 (butyrate response factor 1, ZFP36L1) is an essential regulator of ARE-dependent mRNA decay; zinc finger mutations abolish both ARE-binding activity and mRNA decay-promoting function. |
Functional retroviral cDNA library rescue of mRNA decay-deficient slowC cells, siRNA knockdown, transient transfection with zinc finger mutants, GFP-ARE reporter fluorescence assay |
The EMBO journal |
High |
12198173
|
| 2004 |
BRF1 mRNA decay activity is antagonized by HuR in a functionally antagonistic manner; siRNA knockdown of BRF1 stabilizes ARE-mRNAs while knockdown of HuR destabilizes them, confirming BRF1 as a destabilizer and HuR as a stabilizer of ARE-mRNAs. |
siRNA knockdown of BRF1 and HuR in HT1080 cells stably expressing GFP-ARE reporter, fluorescence measurement |
Nucleic acids research |
Medium |
14976220
|
| 2004 |
Protein kinase B (PKB/Akt) phosphorylates BRF1 at serine 92 (S92), which does not impair ARE binding but induces complex formation with 14-3-3 scaffold protein, resulting in inactivation of BRF1 mRNA decay activity and stabilization of ARE-mRNAs. |
In vitro kinase assay with recombinant BRF1, in vitro mRNA decay assay, co-immunoprecipitation with 14-3-3, phospho-site mutagenesis, in vivo stabilization assays |
The EMBO journal |
High |
15538381
|
| 2006 |
PKB phosphorylates BRF1 at a second regulatory site, Ser203, which cooperates with Ser92; phosphorylation at both sites is required for 14-3-3 binding, and 14-3-3 binding sequesters BRF1 through cytoplasmic relocalization, preventing mRNA decay activity and protecting BRF1 from proteasomal degradation. |
In vitro kinase assay, phospho-site mutagenesis (Ser→Ala), cell fractionation, proteasome inhibitor treatment, PKBα-/- cells, Co-immunoprecipitation with 14-3-3 |
Molecular and cellular biology |
High |
17030608
|
| 2008 |
MAPK-activated protein kinase 2 (MK2) phosphorylates BRF1 at S54, S92, S203, and a C-terminal site, and phosphorylation at S54, S92, and S203 is required for MK2-mediated inhibition of BRF1 ARE-mRNA decay activity; this inhibition does not alter ARE binding or recruitment of mRNA decay enzymes. |
In vitro kinase assays with BRF1 fragments, MK2 co-expression with active/inactive mutants, phospho-site mutagenesis, mRNA decay assays, RNA binding assays |
RNA |
High |
18326031
|
| 2016 |
cAMP-dependent protein kinase (PKA) phosphorylates TIS11b/BRF1 at Ser-54 and Ser-334; phosphomimetic S334D mutation increases BRF1 half-life, enhances mRNA decay activity, and increases interaction with decapping coactivator Dcp1a, while preventing phosphorylation at S334 potentiates interaction with the Ccr4-Not deadenylase subunit Cnot1. |
Site-directed mutagenesis, in vitro kinase assays, specific phosphosite immunodetection, co-immunoprecipitation with Dcp1a and Cnot1, mRNA half-life assays |
Molecular biology of the cell |
High |
27708140
|
| 1999 |
BRF1 (ZFP36L1, the ARE-binding family member) physically interacts with 14-3-3β and 14-3-3τ isoforms via yeast two-hybrid; BRF1 competitively interferes with 14-3-3 binding to cRaf-1 in a trihybrid system, with both full-length proteins required for the interaction. |
Yeast two-hybrid and trihybrid system, mutagenesis of 14-3-3 residue 187 |
DNA and cell biology |
Medium |
10463061
|
| 2011 |
BRF1/TIS11b binds endogenous Dll4 mRNA and represses its expression by interfering with mRNA 3'-end processing/polyadenylation at an AUUUA motif in a weak noncanonical poly(A) signal, shifting the ratio of cleaved to read-through mRNA — a novel function distinct from mRNA stability regulation. |
RNA immunoprecipitation, siRNA knockdown, poly(A) site analysis, mutation of poly(A) signal, quantitative RT-PCR, hypoxia treatment |
Molecular biology of the cell |
Medium |
21832157
|
| 2014 |
BRF1 (Zfp36l1) operates downstream of FGF/ERK MAP kinase signaling in mouse embryonic stem cells to destabilize pluripotency mRNAs (e.g., Nanog), disrupting core pluripotency gene expression and attenuating self-renewal; ERK signaling up-regulates Brf1, and Brf1 preferentially regulates mesendoderm commitment. |
FGF/ERK signaling manipulation, Brf1 overexpression and knockdown in mESCs, mRNA half-life measurements of Nanog, differentiation assays with primitive streak markers |
Proceedings of the National Academy of Sciences |
Medium |
24733888
|
| 1994 |
Yeast BRF (Brf1), the TFIIB-related factor of TFIIIB, binds to the 135-kDa subunit of TFIIIC and to TBP; both the TFIIB-homologous N-terminal half and two conserved regions of the C-terminal half interact with TBP, and BRF (but not TFIIB) binds RNA Pol III subunit C34. |
Protein interaction assays between BRF fragments from S. cerevisiae, K. lactis, and C. albicans; binding to TFIIIC subunit; binding to TBP; defined region of C34 for interaction |
Genes & development |
High |
7995525
|
| 1996 |
Human BRF1 (hBRF, 88 kDa) is a subunit of the 0.38M-TFIIIB complex with TBP; immunodepletion of hBRF severely debilitates transcription from the tRNA-type VAI promoter but does not affect transcription from the TATA box-containing human U6 promoter, demonstrating promoter-type-specific requirement. |
Protein purification, cDNA cloning, immunodepletion from transcription extract, in vitro transcription reconstitution |
Molecular and cellular biology |
High |
8943358
|
| 1998 |
The principal TFIIIB assembly function of yeast Brf1 resides in a C-proximal segment (aa 435-545), while the principal transcription-directing function is in the N-proximal TFIIB-homologous half; split Brf1 fragments (1-282 and 284-596) can reconstitute fully functional TFIIIB-DNA complexes. |
In vitro reconstitution of TFIIIB from Brf1 fragments, in vitro transcription assays, photochemical DNA cross-linking footprinting, interaction assays with TBP mutants |
Molecular and cellular biology |
High |
9710642
|
| 1998 |
Yeast Brf binds a positively charged epitope on the top surface of TBP (residues including R231, R235, R239, etc.), distinct from the TFIIB binding site; Pol II and Pol III TAFs interact with overlapping surfaces of TBP. |
TBP surface mutant analysis (91 mutants), gel-shift complex formation with purified Brf and B", in vitro yeast U6 snRNA transcription assay |
Molecular and cellular biology |
High |
9488486
|
| 2000 |
In Drosophila, TRF1 (TBP-related factor 1) rather than TBP partners with BRF to form a complex required for RNA Pol III transcription of tRNA, 5S, and U6 RNA genes; TRF1:BRF complex is required to reconstitute transcription from immunodepleted extracts. |
Immunoprecipitation, in vitro transcription from immunodepleted extracts supplemented with recombinant proteins, colocalization at polytene chromosome pol III gene sites |
Cell |
High |
10850489
|
| 2000 |
Alternatively spliced human BRF variants have distinct promoter specificities: hBRF1 functions at gene-internal Pol III promoters (5S, VA1, 7SL, EBER2) while hBRF2 is required at the gene-external human U6 promoter, showing that different TFIIIB complexes function at structurally distinct promoters. |
cDNA isolation, immunopurification of hBRF complexes with TBP, in vitro transcription reconstitution at different promoters |
The EMBO journal |
High |
10921893
|
| 2007 |
Human Maf1 represses RNA Pol III transcription through direct interaction with TFIIIB components Brf1 and Brf2, as shown by in vivo Pol III transcription assays. |
RNA pol III luciferase reporter assay, in vivo repression assay through Brf1 and Brf2 |
International journal of biological sciences |
Medium |
17505538
|
| 2013 |
Site-specific cross-linking mapping of yeast Brf1 in the Pol III preinitiation complex reveals: the N-terminal domain contacts multiple Pol III subunits in the active-site cleft (TFIIB-like pattern) plus the Pol III-specific C34 subunit via the cyclin repeat subdomain; the C-terminal domain contains extensive binding sites for TBP and Bdp1. |
Site-specific incorporation of non-natural amino acid photo-crosslinker into Brf1, site-directed hydroxyl radical probing, cross-linking mass spectrometry |
Molecular and cellular biology |
High |
24277937
|
| 2006 |
The principal Brf1-Bdp1 interaction site maps to a 66-amino acid segment of the Brf1 C-terminal domain that forms a two-sided adhesive surface; one side interfaces with TBP and the other anchors Bdp1 binding; the interacting Bdp1 domain includes its 66-amino acid SANT domain. |
Structure-informed site-directed mutagenesis, photochemical protein-DNA cross-linking, deletion analysis of Brf1 and Bdp1 fragments |
The Journal of biological chemistry |
High |
16551611
|
| 2008 |
NMR mapping of the Brf1-Bdp1 interaction reveals that the principal anchorage site of Brf1 (residues 470-495) binds to a convex surface of the Bdp1 SANT domain (helix 1 and helix 3). |
NMR chemical shift perturbation mapping of minimal functional segments of Brf1 and Bdp1, NMR-derived structural model |
Biochemistry |
High |
19086269
|
| 2015 |
Disease-causing BRF1 missense mutations reduce Brf1 occupancy at tRNA target genes in S. cerevisiae, impair cell growth, and reduce Pol III-related transcription activity in vitro, demonstrating that BRF1 mutations causing cerebellar hypoplasia and intellectual disability act by reducing Pol III transcription activity. |
Whole-exome sequencing, zebrafish brf1 CRISPR deletion and morpholino knockdown, in vivo complementation with candidate mutations, ChIP at tRNA genes in yeast, in vitro Pol III transcription assay, yeast growth assay |
Genome research |
High |
25561519
|
| 2018 |
RNF12, a RING domain-containing ubiquitin E3 ligase, physically interacts with BRF1 and catalyzes Lys27- and Lys33-linked polyubiquitination of BRF1, negatively regulating Pol III-dependent transcription and cell proliferation. |
Co-immunoprecipitation, ubiquitination assay in cells and in vitro, linkage-specific ubiquitin mutants, Pol III transcription reporter assay, cell proliferation assay |
The Journal of biological chemistry |
High |
30413534
|
| 2010 |
Ethanol induces RNA Pol III-dependent transcription by upregulating TFIIIB components Brf1 and TBP through a JNK1-dependent pathway; c-Jun mediates this regulation and is directly recruited to Brf1 and TBP gene promoters as well as tRNA gene promoters upon ethanol treatment. |
Cell treatment with ethanol in HepG2 and primary mouse hepatocytes, ChIP for c-Jun at Brf1/TBP promoters and tRNA genes, JNK1 inhibition, transgenic HCV NS5A mice, in vivo alcohol feeding |
The Journal of biological chemistry |
Medium |
21106530
|
| 2017 |
BRF1 interacts with estrogen receptor alpha (ERα) in the nucleus; ERα mediates BRF1 expression, and BRF1 and ERα synergistically regulate Pol III gene transcription; inhibition of ERα by siRNA or tamoxifen reduces cellular BRF1 levels and Pol III gene expression. |
Co-immunoprecipitation, colocalization by immunofluorescence, ChIP, siRNA knockdown of ERα, tamoxifen treatment, colony formation assay |
Molecular oncology |
Medium |
28972307
|
| 2005 |
A Brf1-TBP triple fusion protein (TBP core placed between N- and C-proximal domains of Brf1) effectively replaces both Brf1 and TBP in Pol III transcription in vitro and in vivo, and can recruit Pol III for TATA box-directed transcription in the absence of Bdp1, demonstrating the modular architecture of Brf1. |
In vitro transcription reconstitution, chemical nuclease footprinting of TFIIIB-DNA complexes, in vivo yeast complementation, linear and supercoiled DNA transcription assays |
Proceedings of the National Academy of Sciences |
High |
16227432
|
| 2004 |
Yeast Brf1 induces dissociation of TBP dimers into monomers competent for DNA binding; this requires both the high-affinity TBP-binding C-terminal domain and the TFIIB homology domain of Brf1, acting in concert. |
In vitro TBP dimer dissociation assay, Brf1 domain deletion and mutagenesis |
The Journal of biological chemistry |
Medium |
15190063
|
| 2000 |
Yeast TFIIIB Brf and TBP subunits are sufficient to direct Ty3 retrotransposon integration at the SNR6 transcription initiation site in vitro, in the absence of TFIIIC or the B" subunit of TFIIIB. |
In vitro integration assay with recombinant Brf and TBP at the SNR6 U6 gene, omission of TFIIIC |
The Journal of biological chemistry |
Medium |
10882723
|
| 2007 |
Vaccinia virus infection induces complex formation between hypophosphorylated Rb and Brf1, sequestering Rb and blocking its repression of E2F1 transactivation, thereby altering cell cycle progression. |
Co-immunoprecipitation of Rb-Brf1 complex, Western blot for hypo/hyperphosphorylated Rb, enforced exogenous Rb expression rescue, E2F1 transactivation assay |
Cellular microbiology |
Medium |
17877750
|
| 2019 |
Conditional deletion of Brf1 (Pol III transcription factor) in adult intestine and liver induces apoptosis and is incompatible with organ homeostasis; complete Brf1 knockout causes embryonic lethality at blastocyst stage; BRF1 overexpression rescues deletion phenotypes but does not initiate tumorigenesis. |
Conditional knockout mouse models (intestine, liver, pancreas), heterozygous Brf1 mice, embryonic lethality characterization, histology, apoptosis assays, BRF1 overexpression rescue |
Cell death and differentiation |
High |
30858608
|
| 2018 |
The TFIIE-related Rpc82 subunit of Pol III interacts with Brf1 within the preinitiation complex through a structurally disordered insertion in its WH3 domain; Rpc82 also contacts upstream DNA and the protrusion and wall domains of the Pol III cleft. |
Site-specific photo-crosslinking analysis, hydroxyl radical probing, yeast genetic growth assays, in vitro transcription |
Nucleic acids research |
High |
29177422
|
| 2001 |
TAF3B2 (hBRF1) is the target of repression in p53-mediated cell cycle arrest; TAF3B2 protein stability is markedly reduced in extracts from cell cycle-arrested cells, providing a mechanism by which Pol III transcriptional capacity is reduced during growth arrest. |
p53-inducible cell line, in vitro transcription complementation assays, Western blot for TAF3B2 protein levels in arrested vs. proliferating cells |
The Journal of biological chemistry |
Medium |
11283026
|
| 2006 |
Entry of Brf1 and Bdp1 into the TBP-DNA complex imposes a strict sequence preference for the downstream half of the TATA box (selecting TGTAAATA, matching the SNR6 TATA box), indicating that Brf1 and Bdp1 alter the structure or dynamics of the TBP-DNA complex. |
Altered specificity TBP mutant (TBPm3), iterative in vitro selection assay (SELEX) with Brf1 and Bdp1 |
Nucleic acids research |
Medium |
17028095
|